Cargando…

Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression

BACKGROUND: Corynebacterium pseudotuberculosis, a facultative intracellular bacterial pathogen, is the etiological agent of caseous lymphadenitis (CLA), an infectious disease that affects sheep and goats and it is responsible for significant economic losses. The disease is characterized mainly by ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Santana-Jorge, Karina T. O., Santos, Túlio M., Tartaglia, Natayme R., Aguiar, Edgar L., Souza, Renata F. S., Mariutti, Ricardo B., Eberle, Raphael J., Arni, Raghuvir K., Portela, Ricardo W., Meyer, Roberto, Azevedo, Vasco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869379/
https://www.ncbi.nlm.nih.gov/pubmed/27184574
http://dx.doi.org/10.1186/s12934-016-0479-6
_version_ 1782432310098919424
author Santana-Jorge, Karina T. O.
Santos, Túlio M.
Tartaglia, Natayme R.
Aguiar, Edgar L.
Souza, Renata F. S.
Mariutti, Ricardo B.
Eberle, Raphael J.
Arni, Raghuvir K.
Portela, Ricardo W.
Meyer, Roberto
Azevedo, Vasco
author_facet Santana-Jorge, Karina T. O.
Santos, Túlio M.
Tartaglia, Natayme R.
Aguiar, Edgar L.
Souza, Renata F. S.
Mariutti, Ricardo B.
Eberle, Raphael J.
Arni, Raghuvir K.
Portela, Ricardo W.
Meyer, Roberto
Azevedo, Vasco
author_sort Santana-Jorge, Karina T. O.
collection PubMed
description BACKGROUND: Corynebacterium pseudotuberculosis, a facultative intracellular bacterial pathogen, is the etiological agent of caseous lymphadenitis (CLA), an infectious disease that affects sheep and goats and it is responsible for significant economic losses. The disease is characterized mainly by bacteria-induced caseous necrosis in lymphatic glands. New vaccines are needed for reliable control and management of CLA. Thus, the putative virulence factors SpaC, SodC, NanH, and PknG from C. pseudotuberculosis FRC41 may represent new target proteins for vaccine development and pathogenicity studies. RESULTS: SpaC, PknG and NanH presented better vaccine potential than SodC after in silico analyses. A total of 136 B and T cell epitopes were predicted from the four putative virulence factors. A cluster analysis was performed to evaluate the redundancy degree among the sequences of the predicted epitopes; 57 clusters were formed, most of them (34) were single clusters. Two clusters from PknG and one from SpaC grouped epitopes for B and T-cell (MHC I and II). These epitopes can thus potentially stimulate a complete immune response (humoral and cellular) against C. pseudotuberculosis. Several other clusters, including two from NanH, grouped B-cell epitopes with either MHC I or II epitopes. The four target proteins were expressed in Escherichia coli. A purification protocol was developed for PknG expression. CONCLUSIONS: In silico analyses show that the putative virulence factors SpaC, PknG and NanH present good potential for CLA vaccine development. Target proteins were successfully expressed in E. coli. A protocol for PknG purification is described. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-016-0479-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4869379
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48693792016-05-18 Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression Santana-Jorge, Karina T. O. Santos, Túlio M. Tartaglia, Natayme R. Aguiar, Edgar L. Souza, Renata F. S. Mariutti, Ricardo B. Eberle, Raphael J. Arni, Raghuvir K. Portela, Ricardo W. Meyer, Roberto Azevedo, Vasco Microb Cell Fact Research BACKGROUND: Corynebacterium pseudotuberculosis, a facultative intracellular bacterial pathogen, is the etiological agent of caseous lymphadenitis (CLA), an infectious disease that affects sheep and goats and it is responsible for significant economic losses. The disease is characterized mainly by bacteria-induced caseous necrosis in lymphatic glands. New vaccines are needed for reliable control and management of CLA. Thus, the putative virulence factors SpaC, SodC, NanH, and PknG from C. pseudotuberculosis FRC41 may represent new target proteins for vaccine development and pathogenicity studies. RESULTS: SpaC, PknG and NanH presented better vaccine potential than SodC after in silico analyses. A total of 136 B and T cell epitopes were predicted from the four putative virulence factors. A cluster analysis was performed to evaluate the redundancy degree among the sequences of the predicted epitopes; 57 clusters were formed, most of them (34) were single clusters. Two clusters from PknG and one from SpaC grouped epitopes for B and T-cell (MHC I and II). These epitopes can thus potentially stimulate a complete immune response (humoral and cellular) against C. pseudotuberculosis. Several other clusters, including two from NanH, grouped B-cell epitopes with either MHC I or II epitopes. The four target proteins were expressed in Escherichia coli. A purification protocol was developed for PknG expression. CONCLUSIONS: In silico analyses show that the putative virulence factors SpaC, PknG and NanH present good potential for CLA vaccine development. Target proteins were successfully expressed in E. coli. A protocol for PknG purification is described. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-016-0479-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-16 /pmc/articles/PMC4869379/ /pubmed/27184574 http://dx.doi.org/10.1186/s12934-016-0479-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Santana-Jorge, Karina T. O.
Santos, Túlio M.
Tartaglia, Natayme R.
Aguiar, Edgar L.
Souza, Renata F. S.
Mariutti, Ricardo B.
Eberle, Raphael J.
Arni, Raghuvir K.
Portela, Ricardo W.
Meyer, Roberto
Azevedo, Vasco
Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression
title Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression
title_full Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression
title_fullStr Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression
title_full_unstemmed Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression
title_short Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression
title_sort putative virulence factors of corynebacterium pseudotuberculosis frc41: vaccine potential and protein expression
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869379/
https://www.ncbi.nlm.nih.gov/pubmed/27184574
http://dx.doi.org/10.1186/s12934-016-0479-6
work_keys_str_mv AT santanajorgekarinato putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT santostuliom putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT tartaglianataymer putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT aguiaredgarl putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT souzarenatafs putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT mariuttiricardob putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT eberleraphaelj putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT arniraghuvirk putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT portelaricardow putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT meyerroberto putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression
AT azevedovasco putativevirulencefactorsofcorynebacteriumpseudotuberculosisfrc41vaccinepotentialandproteinexpression